• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基线 SD-OCT 特征可预测糖尿病黄斑水肿模式,并可预测接受玻璃体内注射地塞米松植入物治疗的患者的形态学特征和复发时间。

Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.

机构信息

Department of Surgical Sciences, University of Torino, C. Dogliotti 14, 10126, Turin, Italy.

Department of Ophthalmology, Jules-Gonin Eye Hospital, University of Lausanne, Fondation Asile des aveugles, Lausanne, Switzerland.

出版信息

Acta Diabetol. 2020 Jul;57(7):867-874. doi: 10.1007/s00592-020-01504-w. Epub 2020 Feb 29.

DOI:10.1007/s00592-020-01504-w
PMID:32114643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7311372/
Abstract

AIMS

To evaluate the timing and spectral-domain optical coherence tomography (SD-OCT) features of diabetic macular oedema (DME) recurrence according to baseline OCT patterns in patients treated with dexamethasone implant (DEX-I).

METHODS

This is a retrospective observational study (72 eyes/65 patients). Best-corrected visual acuity, timing of DME recurrence, and SD-OCT pattern [intraretinal cysts (IRC), IRC plus subretinal fluid (mixed), external limiting membrane (ELM), ellipsoid (IS/OS) layer integrity] were assessed at baseline and monthly until first DME recurrence.

RESULTS

Forty-two (58.3%) and 30 (41.6%) DME eyes had an IRC and mixed DME pattern at baseline, respectively. Twenty-four out of thirty mixed eyes (80%) relapsed without subretinal fluid. At baseline, mixed eyes showed similar changes in ELM and IS/OS (60 and 76.6% of eyes, respectively) versus IRC eyes (42.8 and 80.9% of eyes). After DME recurrence, more mixed eyes at baseline showed ELM and IS/OS changes (63.3 and 86.6%) than IRC eyes (50 and 76.2%). 33.3% of mixed eyes had DME recurrence at ≥ 6 months from first DEX-I implant versus 19% of IRC eyes.

CONCLUSIONS

Mixed DME eyes were treated with DEX-I relapse later and more frequently without subretinal fluid than IRC eyes. SD-OCT characteristics of different DME patterns at baseline can predict morphological features and timing of DME recurrence.

摘要

目的

根据接受地塞米松植入物(DEX-I)治疗的患者的基线 OCT 模式,评估糖尿病性黄斑水肿(DME)复发的时间和谱域光相干断层扫描(SD-OCT)特征。

方法

这是一项回顾性观察研究(72 只眼/65 例患者)。在基线和每月评估最佳矫正视力、DME 复发时间以及 SD-OCT 模式[视网膜内囊肿(IRC)、IRC 伴视网膜下液(混合)、外节层(ELM)、椭圆体(IS/OS)层完整性],直到首次 DME 复发。

结果

42 只(58.3%)和 30 只(41.6%)DME 眼在基线时分别具有 IRC 和混合 DME 模式。30 只混合眼中有 24 只(80%)在没有视网膜下液的情况下复发。在基线时,混合眼的 ELM 和 IS/OS 变化相似(分别为 60%和 76.6%的眼)与 IRC 眼(分别为 42.8%和 80.9%的眼)。在 DME 复发后,更多基线时为混合的眼出现 ELM 和 IS/OS 变化(分别为 63.3%和 86.6%),而 IRC 眼(分别为 50%和 76.2%)。与 IRC 眼相比,33.3%的混合眼在首次 DEX-I 植入后≥6 个月出现 DME 复发。

结论

与 IRC 眼相比,混合 DME 眼接受 DEX-I 治疗后复发时间较晚且更频繁,且无视网膜下液。不同 DME 模式的基线 SD-OCT 特征可预测 DME 复发的形态特征和时间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f1c/7311372/1c2e60e4b9d9/592_2020_1504_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f1c/7311372/1c2e60e4b9d9/592_2020_1504_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f1c/7311372/1c2e60e4b9d9/592_2020_1504_Fig1_HTML.jpg

相似文献

1
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.基线 SD-OCT 特征可预测糖尿病黄斑水肿模式,并可预测接受玻璃体内注射地塞米松植入物治疗的患者的形态学特征和复发时间。
Acta Diabetol. 2020 Jul;57(7):867-874. doi: 10.1007/s00592-020-01504-w. Epub 2020 Feb 29.
2
OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.OCT 生物标志物作为经地塞米松植入物治疗的糖尿病性黄斑水肿的功能预后预测指标。
Ophthalmology. 2018 Feb;125(2):267-275. doi: 10.1016/j.ophtha.2017.08.031. Epub 2017 Sep 19.
3
Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.重复玻璃体内注射地塞米松治疗抗VEGF治疗无效的糖尿病性黄斑水肿:结果及频域光学相干断层扫描预测特征
Ophthalmologica. 2018;239(4):205-214. doi: 10.1159/000485852. Epub 2018 Feb 2.
4
Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.地塞米松治疗无反应性糖尿病性黄斑水肿:光学相干断层扫描生物标志物。
Acta Ophthalmol. 2019 Jun;97(4):e540-e544. doi: 10.1111/aos.13935. Epub 2018 Oct 14.
5
Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.玻璃体内注射地塞米松植入物后顽固性糖尿病性黄斑水肿的形态学和功能变化
Br J Ophthalmol. 2017 Jun;101(6):791-795. doi: 10.1136/bjophthalmol-2016-308726. Epub 2016 Sep 13.
6
Prognostic role of optical coherence tomography after switch to dexamethasone in diabetic macular edema.转换为地塞米松治疗后光学相干断层扫描对糖尿病黄斑水肿的预后作用。
Acta Diabetol. 2020 Feb;57(2):163-171. doi: 10.1007/s00592-019-01389-4. Epub 2019 Aug 2.
7
Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.玻璃体内注射皮质类固醇治疗难治性糖尿病性黄斑水肿后,DRIL影响短期视觉预后。
Curr Eye Res. 2021 Sep;46(9):1378-1386. doi: 10.1080/02713683.2021.1878540. Epub 2021 Jan 31.
8
Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.黄斑水肿患者光谱域光学相干断层扫描中高反射点与治疗反应之间的关联
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5958-5967. doi: 10.1167/iovs.17-22725.
9
A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.一项多中心、为期12个月的随机研究,比较地塞米松玻璃体内植入物与雷珠单抗治疗糖尿病性黄斑水肿患者的疗效。
Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):463-473. doi: 10.1007/s00417-016-3472-1. Epub 2016 Sep 8.
10
One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study.糖尿病黄斑水肿患者玻璃体内注射地塞米松植入物后缺血指数变化的 1 年随访:超广角荧光素血管造影研究。
Acta Diabetol. 2020 May;57(5):543-548. doi: 10.1007/s00592-019-01435-1. Epub 2019 Nov 21.

引用本文的文献

1
Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review.玻璃体内抗血管内皮生长因子治疗糖尿病性黄斑水肿后改用玻璃体内地塞米松植入物:综述
Life (Basel). 2024 Jun 3;14(6):725. doi: 10.3390/life14060725.
2
ESASO classification relevance in the diagnosis and evolution in diabetic macular edema patients after dexamethasone implant treatment.ESASO 分类在糖尿病性黄斑水肿患者接受地塞米松植入物治疗后的诊断和演变中的相关性。
Graefes Arch Clin Exp Ophthalmol. 2024 Sep;262(9):2813-2821. doi: 10.1007/s00417-024-06473-2. Epub 2024 Apr 4.
3
The Choroidal Vascularity Index Versus Optical Coherence Tomography Angiography in the Evaluation of the Choroid with a Focus on Age-Related Macular Degeneration.

本文引用的文献

1
Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.玻璃体内地塞米松植入剂(0.7毫克)治疗黄斑水肿患者的真实世界评估:CHROME研究
Clin Ophthalmol. 2015 Jul 10;9:1255-68. doi: 10.2147/OPTH.S80500. eCollection 2015.
2
Sustained release intraocular drug delivery devices for treatment of uveitis.用于治疗葡萄膜炎的缓释眼内给药装置
J Ophthalmic Vis Res. 2011 Oct;6(4):317-29.
3
Immunoregulatory effects of alpha-interferon. Effects on in-vitro antibody synthesis by lymphocytes from patients with rheumatoid arthritis.
脉络膜血管指数与光学相干断层扫描血管造影在年龄相关性黄斑变性中的脉络膜评估中的比较。
Tomography. 2023 Aug 4;9(4):1456-1470. doi: 10.3390/tomography9040116.
4
Prognostic Imaging Biomarkers in Diabetic Macular Edema Eyes Treated with Intravitreal Dexamethasone Implant.玻璃体内注射地塞米松植入物治疗的糖尿病性黄斑水肿眼的预后影像生物标志物
J Clin Med. 2023 Feb 6;12(4):1303. doi: 10.3390/jcm12041303.
5
The Role of Intravitreal Corticosteroids in the Treatment of DME: Predictive OCT Biomarkers.玻璃体内皮质类固醇在 DME 治疗中的作用:预测性 OCT 生物标志物。
Int J Mol Sci. 2022 Jul 8;23(14):7585. doi: 10.3390/ijms23147585.
6
Optical Coherence Tomography Combined with Fluorescein Fundus Angiography under Intelligent Algorithm to Evaluate the Clinical Efficacy of Ranibizumab Combined with Panretinal Photocoagulation in the Treatment of Macular Edema of Diabetic Retinopathy Patients.智能算法下光学相干断层扫描联合荧光素眼底血管造影评估雷珠单抗联合全视网膜光凝治疗糖尿病视网膜病变黄斑水肿的临床疗效。
Comput Math Methods Med. 2022 May 2;2022:2933663. doi: 10.1155/2022/2933663. eCollection 2022.
7
Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex Outcomes.不同临床基线特征对玻璃体内注射地塞米松植入剂Ozurdex疗效的影响。
Clin Ophthalmol. 2021 Oct 14;15:4153-4162. doi: 10.2147/OPTH.S336865. eCollection 2021.
α-干扰素的免疫调节作用。对类风湿性关节炎患者淋巴细胞体外抗体合成的影响。
Ann Rheum Dis. 1985 Mar;44(3):143-7. doi: 10.1136/ard.44.3.143.